Clinical Trial Search

Primary: Percentage of Participants With Verified Prescription Contraceptive Use at the 6-month Assessment — 5; 14; 23 Participants — p=<.001

Primary: Contraceptive Use — 93.43; 94.46; 94.10 percentage of surveys — p=1.0

Primary: Intention to Initiate Contraception — 59 Participants

Primary: Number of Women 'Prepared for Pregnancy\ — 3 participants

Primary: Number of Participants With Continuous Use of Highly Effective Contraceptives Over 9 Months. — 39; 29 Participants — p=>.05

Primary: Contraceptive Continuation — 201; 174; 154; 118 Participants — p=0.46

Primary: Number of Female Participants With Positive PSA at 2-Month Visit — 18; 20 Participants

Primary: Family Planning Visit and Long-acting Reversible Contraception Use at Three and Six Month Follow-up by Condition. — 2; 7; 2; 7 Participants

Primary: Number of Non-pregnant Couples With Modern Contraceptive Use in Past 3 Months — 265; 295 Couple

Primary: Pregnancy Rates — 25 Participants

Primary: Potential Efficacy: Effective Contraception Initiation Rates [Time Frame: Enrollment, 12 Weeks Post-enrollment (2 Weeks Post Close of Intervention)] — 14; 14 Participants

Primary: Contraceptive Acceptability and Use of Contraceptives During the 6-month Follow-up — 121; 86 participants

Primary: Continuation Rates — 82; 78; 83 participants

Primary: Feasibility of Application — 4.47; 4.52; 4.16; 4.26 units on a scale

Primary: Change in Contraceptive Knowledge Assessment (CKA) Score — 0.90; 1.6 scores on a scale — p=<0.0001

Primary: Decisional Conflict Scale Score — 15; 10; 0; 0 score on a scale

Primary: Number of Participants With Ovulation With Implant-alone — 7; 0 Participants

Primary: Number of Participants Choosing Each Hormonal Contraceptive Method Before and After Counseling — 1207; 1199; 60; 131 Participants — p=0.705

Primary: ABILITY TO FOLLOW POSTPARTUM TEENS FOR 1 YEAR. — 22; 16 Participants

Primary: Number of Participants Using an Effective Contraceptive Method 6 Weeks After Abortion — 55; 55 Participants

Primary: Weight — 3.2; 6.8; 7.0 percent weight lost — p=<0.05

Primary: Percent of HIV Target Immune Cells Within Female Genital Mucosa and Blood — 26.6; 22.8; 16.9; 22.4 percentage of HIV target immune cells

Primary: Unintended Pregnancy — 46; 25 Participants

Primary: Self-reported Uptake of Effective Ongoing Contraception (Not Condoms) — 5; 13; 22; 0 participants — p=<0.001

Primary: Number of Participants With Contraceptive Implant Continuation at Six Months Postpartum — 15; 7 Participants

Primary: Number of Couples With Uptake of Any High Efficacy Contraceptive Method — 20; 9; 15; 26 Couple — p=0.20

Primary: All Users Pregnancy Rates Based on Pearl Index (PI) Analyses for 28-Day Cycles and Broken Out by Subpopulations Defined by Participant Weight, Using the 7-Day Rule…

Primary: Contraception Use Self-efficacy Scale Score (Aim 1b) — 23.2; 22.45; 25.22; 23.04 Scores on a scale — p=0.011

Primary: Number of Patients Who Receive Contraception by Two Months Postpartum — 474; 339 Participants — p=0.12

Primary: Time to Lactogenesis Stage II — 64.3; 65.2 hours — p=<0.05